UPDATE 1-Valeant picks up AstraZeneca psoriasis drug after Amgen exit
 

UPDATE 1-Valeant picks up AstraZeneca psoriasis drug after Amgen exit
Sept 1 (Reuters) - Canada's Valeant Pharmaceuticals International Inc is buying rights to AstraZeneca Plc's late-stage experimental psoriasis drug brodalumab after it was dropped by Amgen Inc in May.
http://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA [IMG]http://feeds.feedburner.com/~ff/reuters/companyNews?i=1LMvi2-ixCg:_7**FJplxe0:V_sGLiPBpWU[/IMG] [IMG]http://feeds.feedburner.com/~ff/reuters/companyNews?i=1LMvi2-ixCg:_7**FJplxe0:F7zBnMyn0Lo[/IMG]
http://feeds.feedburner.com/~r/reute...~4/1LMvi2-ixCg